U.S. Healthtech Stock News

Third quarter beat and credit upgrade put Deluxe in a stronger spot Deluxe (DLX) just delivered a stronger than expected third quarter and picked up a credit upgrade to B+ with a stable outlook, a one two that signals improving balance sheet strength. See our latest analysis for Deluxe. The upbeat quarter and credit upgrade seem to be feeding into a slow but positive shift in sentiment, with Deluxe’s share price returning 10.29% over the last month and a solid 58.60% three year total...

MSA Safety (MSA) has quietly outperformed the broader market over the past month, with the stock climbing about 4% even as its one year return remains slightly negative and volatility stays contained. See our latest analysis for MSA Safety. Zooming out, that recent 1 month share price strength sits against a softer backdrop, with the share price still slightly lower year to date while the 3 year total shareholder return of about 30% shows the longer term wealth creation story remains intact...

Kaiser Aluminum (KALU) has quietly put together a strong run, with the stock up roughly 19% over the past month and about 40% in the past 3 months, drawing fresh valuation questions. See our latest analysis for Kaiser Aluminum. Zooming out, that recent surge sits on top of a solid year to date, with a share price return of roughly 55% and a three year total shareholder return above 60%. This suggests momentum is still building as investors reassess its recovery story and earnings power. If...

Photronics (PLAB) just turned heads with a fourth quarter that delivered sharp profit growth, even as revenue slipped slightly. The market is paying attention to what that says about margins and demand. See our latest analysis for Photronics. The strong fourth quarter and upbeat 2026 guidance helped propel Photronics’ 1 month share price return to about 72%, contributing to a 5 year total shareholder return of roughly 229%, suggesting momentum is firmly building rather than fading. If this...

Earlier this month, Snap Inc. expanded its board from eleven to twelve members and appointed Matthew McRae, the long‑time technology executive and current Arlo Technologies CEO, as a director effective December 4, 2025. By adding a leader with deep experience in connected devices, consumer technology, and digital platforms, Snap may be reinforcing its focus on product innovation and operational discipline at the board level. We’ll now consider how bringing Matthew McRae’s technology and...

Flywire (FLYW) just took another deliberate step into Asian education payments by partnering with TenPay Global so Chinese students can use Weixin Pay for tuition at universities in South Korea and Malaysia. See our latest analysis for Flywire. The TenPay Global deal lands at a time when sentiment on Flywire is still cautious, with the share price at $14.77 and a year to date share price return of negative 26.52 percent. However, the 90 day share price return of 10.64 percent and 7 day share...

CVB Financial (CVBF) has quietly drifted lower over the past year even as its underlying business keeps posting steady revenue and profit growth, which naturally raises the question: is the current share price underestimating its earnings power? See our latest analysis for CVB Financial. At around $19.92, the share price has climbed in recent weeks with a 1 month share price return of 5.62 percent. However, the 1 year total shareholder return of negative 9.93 percent shows momentum is still...

Bausch + Lomb (NYSE:BLCO) just got a confidence boost, with recent analyst upgrades helping nudge the stock higher even as the company reshapes its balance sheet through a multibillion dollar debt refinancing. See our latest analysis for Bausch + Lomb. The recent analyst upgrades and debt refinancing have helped the share price regain some momentum, with a 30 day share price return of about 9% and a 3 year total shareholder return of roughly 15%, even though year to date share price...

Centessa Pharmaceuticals (CNTA) just put its orexin strategy front and center by naming Mario Alberto Accardi as CEO and board member, a leadership shift closely aligned with its focused neuroscience pipeline. See our latest analysis for Centessa Pharmaceuticals. The leadership reshuffle lands after a sharp run up in the stock, with Centessa’s 90 day share price return of 20.39 percent and one year total shareholder return of 59.99 percent suggesting momentum is still building despite recent...

Halliburton (HAL) just put a clearer marker on its energy transition strategy by expanding its VoltaGrid partnership to secure manufacturing for 400 MW of modular natural gas power aimed at hyperscale data centers across the Eastern Hemisphere. See our latest analysis for Halliburton. The VoltaGrid deal lands after a busy few weeks for Halliburton, including new C suite appointments and upcoming earnings. It also rides on solid momentum, with a 90 day share price return of 27.65 percent and a...

Academy Sports and Outdoors (ASO) just delivered a Q3 update that combined steady growth with a busier store rollout, lifting full-year guidance even as sales came in slightly below expectations. See our latest analysis for Academy Sports and Outdoors. The Q3 beat on profits, brisk store openings, and a fresh dividend declaration have helped flip sentiment. A strong 30 day share price return of 24.11% contrasts with a muted 1 year total shareholder return of 1.98%, suggesting momentum is...

Citizens Financial Group (CFG) just cut its prime lending rate from 7% to 6.75% while also getting downgraded by Baird to Neutral, a pairing that gives investors plenty to unpack. See our latest analysis for Citizens Financial Group. Those moves come after a strong run, with Citizens Financial Group’s share price up solidly so far this year and its three year total shareholder return above 70%. This suggests momentum is still intact even as expectations cool a little. If this shift in bank...

Woodward (WWD) just moved to update its corporate rulebook, proposing to scrap some supermajority voting thresholds while also eliminating cumulative voting in director elections. This governance tweak could subtly reshape shareholder influence. See our latest analysis for Woodward. These governance moves come after a powerful run, with the share price up 73.85% year to date and a 1 year total shareholder return of 71.02%. This hints that momentum is still firmly on Woodward's side despite a...

Savara (SVRA) just picked up a meaningful intellectual property win, with the European Patent Office signaling its intention to grant a patent on the liquid formulation of MOLBREEVI for autoimmune PAP. See our latest analysis for Savara. That backdrop helps explain why investors have leaned in, with the stock logging a roughly 61 percent 1 month share price return and a powerful multi year total shareholder return while momentum continues to build around MOLBREEVI. If this kind of rare...

On December 11, 2025, NiSource Inc. entered into a Seventh Amended and Restated Revolving Credit Agreement, lifting its revolving credit capacity by US$650 million to US$2.50 billion, extending the facility’s maturity to December 11, 2030, and increasing standby letter of credit capacity to US$175 million. The agreement not only enhances NiSource’s liquidity but also removes ESG-linked rate adjustments, signaling a shift toward simpler, more conventional financing terms that could influence...

In recent weeks, insiders and major beneficial owners, including media and internet group IAC, have purchased substantial additional stakes in MGM Resorts International, reflecting internal conviction about the company’s prospects in areas such as online gaming and digital sports betting. This wave of insider buying, coming alongside MGM’s ongoing push into higher-margin digital offerings and premium resort experiences, offers investors a fresh window into how key stakeholders view the...

Recent commentary highlighted Nelnet’s past two years of approximately 18% annual revenue growth and earnings expansion supported by share buybacks, reflecting growing market share across its student loan servicing, education technology, payment processing, and banking activities. An interesting angle for investors is management’s track record of allocating capital into profitable ventures, reflected in a five-year return on equity of about 10.7%, which reinforces confidence in how the...

Earlier this month, Agilent Technologies released new 21 CFR Part 11 compliance software for its xCELLigence RTCA eSight system, adding secure user authentication, electronic signatures, and full audit trails so the live-cell analysis platform can be used in GMP-regulated manufacturing and quality control as well as research and development labs. This upgrade extends the same real-time cell analysis platform across the pharma and biopharma value chain, aligning with growing demand for...

Earlier this month, Mission announced on AWS Marketplace six integrated multi-product cloud solutions built with partners including CDW, CrowdStrike, New Relic, Nutanix, Vega Cloud, and Mission’s own managed services to streamline cloud governance, security, and operations for enterprise customers. The launch positions CDW more firmly as an orchestrator of complex, multi-vendor cloud and security stacks, tying its enterprise technology expertise directly into AI-ready and compliance-focused...

Earlier today, J.P. Morgan initiated coverage on SouthState Bank with an Overweight rating, reflecting a positive view of the bank’s prospects and positioning. This new coverage introduces a fresh institutional lens on SouthState’s growth potential, which can meaningfully shape how investors assess the bank’s longer-term trajectory. We’ll now explore how J.P. Morgan’s favorable initiation fits with SouthState’s existing growth narrative and what it might mean for the story ahead. Trump has...

Erasca, Inc. recently secured U.S. patent protection through 2043 for its pan-RAS molecular glue candidate ERAS-0015, advanced ERAS-0015 and ERAS-4001 through Phase 1 trials in RAS/KRAS-mutant solid tumors, promoted Robert Shoemaker, Ph.D., to chief scientific officer, and reported US$362,000,000 in cash, cash equivalents, and marketable securities as of September 30, 2025. This combination of extended patent life, progressing RAS-targeted programs, strengthened scientific leadership, and...

Earlier this month, Dexcom launched Dexcom Academy across several EMEA markets, offering personalised, app-based training for healthcare professionals on its CGM products and broader diabetes care. This education platform, co-created with clinicians and focused on practical, consultation-ready content, signals Dexcom’s effort to deepen CGM adoption while easing clinical workloads. We’ll now examine how this push into clinician-focused education could influence Dexcom’s longer-term investment...

Post Holdings has recently completed a private offering announcement for US$1.30 billion of unsecured senior notes due 2036 and moved to redeem the remaining US$1.24 billion of its 5.50% senior notes due 2029 at a small premium, ending interest accrual on those securities from December 17, 2025. This refinancing reshapes Post’s debt profile by extending maturities, potentially altering interest costs and freeing up flexibility for future capital allocation priorities. We’ll now examine how...

Wondering if LPL Financial Holdings at around $380 a share is still worth buying, or if the big gains are already behind it? You are not the only one trying to figure out what is really priced in. The stock has climbed 2.7% over the last week, 2.8% over the past month, and is now up 16.1% year to date, building on a powerful 277.3% gain over five years that signals investors have been willing to pay up for its story. Behind those moves, the big narrative has been LPL's continued expansion of...